NL6616277A - - Google Patents
Info
- Publication number
- NL6616277A NL6616277A NL6616277A NL6616277A NL6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1598865A CH474486A (de) | 1965-11-19 | 1965-11-19 | Verfahren zur Herstellung neuer Diphenylharnstoffe |
| CH1409266 | 1966-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6616277A true NL6616277A (en:Method) | 1967-05-22 |
Family
ID=25713607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6616277A NL6616277A (en:Method) | 1965-11-19 | 1966-11-18 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US3560566A (en:Method) |
| AT (1) | AT269166B (en:Method) |
| BE (1) | BE689902A (en:Method) |
| BR (1) | BR6684680D0 (en:Method) |
| CH (1) | CH474486A (en:Method) |
| DE (1) | DE1568349A1 (en:Method) |
| DK (1) | DK118457B (en:Method) |
| FR (3) | FR1504097A (en:Method) |
| GB (1) | GB1142066A (en:Method) |
| NL (1) | NL6616277A (en:Method) |
| SE (1) | SE323360B (en:Method) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1311432A (en) * | 1971-01-07 | 1973-03-28 | Ici Ltd | Guanidine derivatives their preparation and antiviral compositions containing them |
| DE3360148D1 (en) * | 1982-02-10 | 1985-06-05 | Beecham Group Plc | Guanidine derivatives |
| US5238941A (en) * | 1988-03-25 | 1993-08-24 | Ciba-Geigy Corporation | Arylhydrazones and pharmaceutical compositions thereof |
| US4971986A (en) * | 1988-03-25 | 1990-11-20 | Ciba-Geigy Corporation | Arylhydrazones useful as SAMDC inhibitors |
| US5599984A (en) * | 1994-01-21 | 1997-02-04 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
| US6008255A (en) * | 1994-01-21 | 1999-12-28 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
| WO2002000613A2 (en) * | 2000-06-27 | 2002-01-03 | Axxima Pharmaceuticals Ag | Inhibitors of hepatitis b virus infection |
| US20050282909A1 (en) * | 2003-11-14 | 2005-12-22 | Diks Sander H | Guanylhydrazones in methods of treatment or diagnosis as modulators of signal transduction |
| PL1778265T3 (pl) * | 2004-08-17 | 2013-10-31 | Ferring Bv | Związki guanylohydrazonowe, kompozycje, sposoby wytwarzania i stosowania |
| US8912214B2 (en) * | 2005-07-29 | 2014-12-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of Chk2 kinase inhibitors for cancer treatment |
| CA2690410C (en) * | 2007-06-12 | 2015-09-29 | Provid Pharmaceuticals, Inc. | Kinase inhibitors, compositions thereof, and methods of use therewith |
| WO2014193969A2 (en) * | 2013-05-28 | 2014-12-04 | The Regents Of The University Of California | Compounds for the treatment of hypertension and hypertensive end stage renal disease |
-
1965
- 1965-11-19 CH CH1598865A patent/CH474486A/de not_active IP Right Cessation
-
1966
- 1966-11-11 DE DE19661568349 patent/DE1568349A1/de active Pending
- 1966-11-14 GB GB50898/66A patent/GB1142066A/en not_active Expired
- 1966-11-15 US US594386A patent/US3560566A/en not_active Expired - Lifetime
- 1966-11-17 FR FR83919A patent/FR1504097A/fr not_active Expired
- 1966-11-18 NL NL6616277A patent/NL6616277A/xx unknown
- 1966-11-18 SE SE15811/66A patent/SE323360B/xx unknown
- 1966-11-18 BE BE689902D patent/BE689902A/xx unknown
- 1966-11-18 BR BR184680/66A patent/BR6684680D0/pt unknown
- 1966-11-18 DK DK598166AA patent/DK118457B/da unknown
- 1966-11-18 AT AT119368A patent/AT269166B/de active
-
1967
- 1967-02-14 FR FR94793A patent/FR6139M/fr not_active Expired
- 1967-02-14 FR FR94794A patent/FR6153M/fr not_active Expired
- 1967-07-11 US US652409A patent/US3560557A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| BE689902A (en:Method) | 1967-05-18 |
| US3560557A (en) | 1971-02-02 |
| US3560566A (en) | 1971-02-02 |
| FR6139M (en:Method) | 1968-06-24 |
| FR1504097A (fr) | 1967-12-01 |
| DE1568349A1 (de) | 1970-02-12 |
| DK118457B (da) | 1970-08-24 |
| CH474486A (de) | 1969-06-30 |
| BR6684680D0 (pt) | 1973-12-18 |
| FR6153M (en:Method) | 1968-07-01 |
| AT269166B (de) | 1969-03-10 |
| GB1142066A (en) | 1969-02-05 |
| SE323360B (en:Method) | 1970-05-04 |